ANI PHARMACEUTICALS INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Ani Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2012 to Q3 2024.
  • Ani Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$24.2M, a 343% decline year-over-year.
  • Ani Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$7.09M, a 153% decline year-over-year.
  • Ani Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2023 was $18.8M.
  • Ani Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$47.9M, a 12.4% decline from 2021.
  • Ani Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$42.6M, a 88.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$7.09M -$24.2M -$34.1M -343% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $27M -$2.29M -$8.53M -137% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $35.5M $18.2M +$16.8M +1165% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $18.8M $1.16M +$5.4M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $13.4M $9.94M +$18.5M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$5.16M $6.25M +$21.2M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$26.3M $1.44M +$21.6M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$47.9M -$4.24M +$19.9M +82.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$67.8M -$8.6M -$4.15M -93.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$63.6M -$14.9M -$817K -5.79% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$62.8M -$20.1M -$20.2M -23507% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$42.6M -$24.1M -$20.5M -564% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$22.1M -$4.45M -$4.88M -1125% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$17.2M -$14.1M -$1.77M -14.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$15.5M $86K +$7.1M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$22.5M -$3.64M +$1.2M +24.8% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-11
Q3 2020 -$23.7M $434K -$3.46M -88.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 -$20.3M -$12.3M -$18.9M -287% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$1.37M -$7.01M -$7.46M -1661% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $6.09M -$4.84M -$10.3M -189% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $16.4M $3.9M -$1.14M -22.7% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-11
Q2 2019 $17.5M $6.59M +$3.81M +137% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-11
Q1 2019 $13.7M $449K -$1.8M -80% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-11
Q4 2018 $15.5M $5.43M +$15.1M Oct 1, 2018 Dec 31, 2018 10-K 2021-03-11
Q3 2018 $435K $5.04M +$317K +6.72% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $118K $2.78M +$96K +3.58% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $22K $2.25M +$1.1M +95.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$1.08M -$9.63M -$8.55M -792% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $7.47M $4.72M +$2.18M +85.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $5.3M $2.68M +$1.56M +138% Mar 31, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $3.74M $1.15M -$194K -14.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $3.93M -$1.08M -$3.96M -138% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $7.89M $2.54M -$2.02M -44.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $9.91M $1.13M -$2.45M -68.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $12.4M $1.35M -$3.02M -69.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $15.4M $2.88M -$18.1M -86.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $33.5M $4.56M -$2.19M -32.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $35.7M $3.57M +$5.93M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $29.8M $4.37M +$1.01M +30.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 $28.7M $21M +$17.6M +512% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-02
Q3 2014 $11.2M $6.75M +$5.56M +466% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-03
Q2 2014 $5.62M -$2.36M +$2.22M +48.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 $3.4M $3.36M +$3.1M +1192% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 $301K $3.43M Oct 1, 2013 Dec 31, 2013 10-K 2016-02-23
Q3 2013 $1.19M +$1.57M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$4.58M -$4.62M -13038% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $260K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q3 2012 -$377K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $35.4K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.